Addition of intravitreal carboplatin with melphalan for management of vitreous seeding in retinoblastoma
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cellular and Molecular Neuroscience,Sensory Systems,Ophthalmology
Link
https://link.springer.com/content/pdf/10.1007/s00417-022-05903-3.pdf
Reference27 articles.
1. Ghassemi F, Shields CL, Ghadimi H et al (2014) Combined intravitreal melphalan and topotecan for refractory or recurrent vitreous seeding from retinoblastoma. JAMA Ophthalmol 132:936–941. https://doi.org/10.1001/jamaophthalmol.2014.414
2. Shields CL, Bianciotto CG, Jabbour P et al (2011) Intra-arterial chemotherapy for retinoblastoma: report no. 1, control of retinal tumors, subretinal seeds, and vitreous seeds. Arch Ophthalmol 129(11):1399–1406. https://doi.org/10.1001/archophthalmol.2011.150
3. Shields CL, Manjandavida FP, Arepalli S et al (2014) Intravitreal melphalan for persistent or recurrent retinoblastoma vitreous seeds: preliminary results. JAMA Ophthalmol 132:319–325. https://doi.org/10.1001/jamaophthalmol.2013.7666
4. Abramson DH, Marr BP, Dunkel IJ et al (2012) Intra-arterial chemotherapy for retinoblastoma in eyes with vitreous and/or subretinal seeding: 2-year results. Br J Ophthalmol 96:499–502. https://doi.org/10.1136/bjophthalmol-2011-300498
5. Manjandavida FP, Stathopoulos C, Zhang J et al (2019) Intra-arterial chemotherapy in retinoblastoma - a paradigm change. Indian J Ophthalmol 67:740–754. https://doi.org/10.4103/ijo.IJO_866_19
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Safety of intravitreal chemotherapy in the management of retinoblastoma: A systematic review of the literature;Critical Reviews in Oncology/Hematology;2024-08
2. Update on chemotherapy modalities for retinoblastoma: Progress and challenges;Asia-Pacific Journal of Ophthalmology;2024-03
3. Lipid-nanoparticles-based co-delivery of black phosphorus quantum dots and melphalan by photothermal therapy combined with chemotherapy for retinoblastoma;Polymer Testing;2023-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3